Successful treatment of myeloma cast nephropathy using bortezomib-based chemotherapy plus selective plasma exchange

CEN Case Reports
Mayuko KawabeTakashi Yokoo

Abstract

Myeloma cast nephropathy is a major complication of multiple myeloma. Recent evidence has demonstrated that the earlier induction of bortezomib-based chemotherapy with plasma exchange (PE) provides better results for kidney function and patient survival. Due to its non-selectivity, PE with albumin replacement carries the risk of fibrinogen loss, leading to bleeding. We herein report a case of successful treatment of myeloma cast nephropathy using bortezomib-based chemotherapy and selective PE. A 61-year-old woman who had a 20-year history of type II diabetes mellitus was admitted to our hospital for the evaluation of hypercalcemia, severe kidney dysfunction, and anemia. Subsequent bone marrow evaluation and renal biopsy revealed that she had multiple myeloma (IgG-κ) and myeloma cast nephropathy. Ten days after admission, bortezomib-based chemotherapy with selective PE achieved rapid and thorough free light-chain (FLC) reduction; within a month, her kidney function had been recovered (creatinine level, 1.2 mg/dl). Her serum fibrinogen level was not reduced, and no bleeding complication occurred. Five months later, autologous hematopoietic stem-cell transplantation was performed successfully, and the patient's kidney function was...Continue Reading

References

Feb 15, 1997·The Journal of Clinical Investigation·Z Q Huang, P W Sanders
Jul 26, 2006·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Hawk KimCheolwon Suh
Jun 27, 2007·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Nelson Leung, S Vincent Rajkumar
Sep 9, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Heinz LudwigNiklas Zojer
Apr 23, 2011·Journal of the American Society of Nephrology : JASN·Colin A HutchisonNelson Leung
Jun 17, 2011·The New England Journal of Medicine·Brian L BurnetteS Vincent Rajkumar
Nov 3, 2011·Nature Reviews. Nephrology·Colin A HutchisonUNKNOWN International Kidney and Monoclonal Gammopathy Research Group
Mar 16, 2012·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Samih H NasrNelson Leung
Apr 10, 2012·The Journal of Clinical Investigation·Wei-Zhong YingPaul W Sanders
Oct 2, 2012·Clinical Journal of the American Society of Nephrology : CJASN·Nelson LeungAngela Dispenzieri
Jul 5, 2015·Japanese Journal of Clinical Oncology·Megumi HoriUNKNOWN Japan Cancer Surveillance Research Group

❮ Previous
Next ❯

Citations

May 22, 2018·Therapeutic Apheresis and Dialysis : Official Peer-reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy·Satoko MiyamotoTomokazu Okado

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.